UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000044694
Receipt No. R000050955
Scientific Title The relationship between hyperlactatemia and acute kidney injury in adult cardiac surgery with cardiopulmonary bypass. A single-centre backwards-looking study
Date of disclosure of the study information 2021/06/29
Last modified on 2021/06/29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Hyperlactatemia is an indicator of acute kidney injury in adult cardiac surgery with cardiopulmonary bypass.
Acronym Hyperlactatemia is an indicator of acute kidney injury in adult cardiac surgery with cardiopulmonary bypass.
Scientific Title The relationship between hyperlactatemia and acute kidney injury in adult cardiac surgery with cardiopulmonary bypass. A single-centre backwards-looking study
Scientific Title:Acronym The relationship between hyperlactatemia and acute kidney injury in adult cardiac surgery with cardiopulmonary bypass. A single-centre backwards-looking study
Region
Japan

Condition
Condition Cardiac disease
Classification by specialty
Anesthesiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Clarifying the association between hyperlactatemia and AKI in adults after cardiopulmonary bypass and its usefulness for clinical diagnosis
Basic objectives2 Others
Basic objectives -Others Prognostic value
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Onset of acute kidney injury
Key secondary outcomes ICU length of stay, mortality, P/F ratio, use of pressure-boosting drugs, postoperative hemoglobin level, postoperative hematocrit level, creatinine reduction rate, etc.

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Adult patients undergoing cardiac operations with cardiopulmonary bypass between 1st October 2016 and 14th June 2021
Key exclusion criteria Emergency surgery, surgery on patients under 18 years of age, patients under total intravenous anaesthesia, patients with end-stage renal failure (GFR <15 mL/min/1.73m2) and dialysis patients, patients with alcoholism, patients on preoperative artificial heart lungs, other unsuitable cases
Target sample size 150

Research contact person
Name of lead principal investigator
1st name Kosuke
Middle name
Last name Hamada
Organization Oji General Hospital
Division name Anesthesiology
Zip code 053-8506
Address 3-4-8 Wakakakusa-cho, Tomakomai City, Hokkaido
TEL 0144328111
Email hamakou21@hotmail.com

Public contact
Name of contact person
1st name Kosuke
Middle name
Last name Hamada
Organization Oji General Hospital
Division name Anesthesiology
Zip code 053-8506
Address 3-4-8 Wakakakusa-cho, Tomakomai City, Hokkaido
TEL 0144328111
Homepage URL
Email hamakou21@hotmail.com

Sponsor
Institute Oji General Hospital
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor Sapporo Medical University
Name of secondary funder(s)

IRB Contact (For public release)
Organization Oji General Hospital
Address 3-4-8 Wakakakusa-cho, Tomakomai City, Hokkaido
Tel 0144328111
Email hamakou21@hotmail.com

Secondary IDs
Secondary IDs YES
Study ID_1 OGH2021-15
Org. issuing International ID_1 Oji General Hospital
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 06 Month 29 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2021 Year 05 Month 31 Day
Date of IRB
Anticipated trial start date
2021 Year 06 Month 22 Day
Last follow-up date
2024 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information The study protocol is disclosed in an opt-out format on the institutional web-site, giving an opportunity to refuse consent. If there is a disagreement application during the investigation period, the relevant data will be deleted.

Management information
Registered date
2021 Year 06 Month 29 Day
Last modified on
2021 Year 06 Month 29 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050955

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.